Latest Industry Insights

As global scientific and regulatory landscapes shift, companies across the life sciences sector are under growing pressure to adapt. Hear how Phenomenex are taking a proactive approach.

Illumina’s Rami Mehio discusses the whole-genome sequencing of 490,640 UK Biobank participants with Molly Coddington for Technology Networks.

This article explores the unique characteristics and challenges of life sciences marketing, offering insights on how to achieve meaningful engagement with a highly specialized audience.

In this article, discover how the FDA and NIH are replacing animal testing with human models, such as organoids, featuring expert insights on safer, faster and ethical drug development.

Explore why cell and gene therapy manufacturing failures are now a leading cause of FDA rejections and how to avoid them.

Stem cell therapy using iPSC technology on the surface of the eye could cure blindness by replacing damaged corneal cells – a new hope for vision restoration.

Discover how AI-powered ADMET modeling can enable the prediction of toxicity and pharmacokinetics with depth, transparency and scientific rigor.

At the 2025 American Society for Mass Spectrometry (ASMS) conference, experts shared how the industry is embracing sustainable practices while driving innovation and productivity.

To explore AI's growing impact, Technology Networks asked experts at the 2025 ASMS conference a single question: How can AI support analytical science workflows, both today and in the years ahead?

Technology Networks recently spoke with Cristiano Tunesi to learn more about how cerebrospinal fluid biomarkers are transforming Alzheimer’s diagnosis, offering earlier and more accurate detection to guide treatment and improve outcomes.